These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27028699)

  • 21. Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.
    Damen L; Grootjen LN; Juriaans AF; Donze SH; Huisman TM; Visser JA; Delhanty PJD; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2021 May; 94(5):774-785. PubMed ID: 33296519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effects of clomipramine on diurnal sleepiness and respiratory parameters in a a case of Prader-Willi syndrome].
    Esnault-Lavandier S; Mabin D
    Neurophysiol Clin; 1998 Dec; 28(6):521-5. PubMed ID: 9894231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding.
    McAllister CJ; Whittington JE; Holland AJ
    Int J Obes (Lond); 2011 Feb; 35(2):188-97. PubMed ID: 20680019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL; Sinnayah P; Mathai ML
    Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.
    Yaryura-Tobias JA; Grunes MS; Bayles ME; Neziroglu F
    Eat Weight Disord; 1998 Dec; 3(4):163-7. PubMed ID: 10728166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.
    Butler JV; Whittington JE; Holland AJ; McAllister CJ; Goldstone AP
    Dev Med Child Neurol; 2010 Jun; 52(6):e88-93. PubMed ID: 20041936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Marked weight loss in two female patients with prader-willi syndrome by behavioral modification and improvement of the environment].
    Nishida K; Okada Y; Mori H; Hirose A; Tanikawa T; Arao T; Morita E; Tanaka Y
    J UOEH; 2006 Mar; 28(1):65-73. PubMed ID: 16541741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Care continuity for patients with Prader-Willi syndrome during transition from childhood to adulthood].
    Saitoh S
    Nihon Rinsho; 2010 Jan; 68(1):141-4. PubMed ID: 20077807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of naltrexone, an oral beta-endorphin antagonist, in children with the Prader-Willi syndrome.
    Zlotkin SH; Fettes IM; Stallings VA
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1229-32. PubMed ID: 2944913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring patterns of unwanted behaviours in adults with Prader-Willi syndrome.
    Pignatti R; Mori I; Bertella L; Grugni G; Giardino D; Molinari E
    J Appl Res Intellect Disabil; 2013 Nov; 26(6):568-77. PubMed ID: 23613474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lisdexamphetamine as a novel therapy for hyperphagia in Prader-Willi syndrome.
    Preddy J; Smith-Wade S; Houghton K
    J Paediatr Child Health; 2023 Mar; 59(3):570-572. PubMed ID: 36749028
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychiatric disorders in a cohort of individuals with Prader-Willi syndrome.
    Shriki-Tal L; Avrahamy H; Pollak Y; Gross-Tsur V; Genstil L; Hirsch HJ; Benarroch F
    Eur Psychiatry; 2017 Jul; 44():47-52. PubMed ID: 28545008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the causes of obesity in children with trisomy 21: hyperphagia vs physical inactivity.
    Foerste T; Sabin M; Reid S; Reddihough D
    J Intellect Disabil Res; 2016 Sep; 60(9):856-64. PubMed ID: 26936540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying the Burden of Hyperphagia in Prader-Willi Syndrome Using Quality-Adjusted Life-years.
    Lavelle TA; Crossnohere NL; Bridges JFP
    Clin Ther; 2021 Jul; 43(7):1164-1178.e4. PubMed ID: 34193348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prader-Willi syndrome.
    Lennox N; Cook A; Slater H
    Aust Fam Physician; 1997 May; 26(5):560-3. PubMed ID: 9170672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurobiological drive for overeating implicated in Prader-Willi syndrome.
    Zhang Y; Wang J; Zhang G; Zhu Q; Cai W; Tian J; Zhang YE; Miller JL; Wen X; Ding M; Gold MS; Liu Y
    Brain Res; 2015 Sep; 1620():72-80. PubMed ID: 25998539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.
    Miller JL; Linville TD; Dykens EM
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):23-9. PubMed ID: 23893676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.